Innomed Tech Ltd. is a listed company. Filings by its managers are published through SEDI. The last twelve months, up to 18 October 2026, brought 4 filings signed by 2 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Over the last twelve months, not one insider purchase of Innomed Tech Ltd. stock was filed.
Across the 2,144 companies tracked on its exchange, the median is 12 filings; at 4 filings, this issuer sits below that mark.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
4 of 4 declarations
Innomed Tech Ltd. is a company listed on the XTSE, specializing in the development of innovative medical technologies. It focuses on improving healthcare through advanced technological solutions.